Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Licitra

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
ESMO Open|January 17, 2026
A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancersS Alfieri, S Rota, R Romanò, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2020
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III studyR L Ferris, R Haddad, C Even, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Radiochemotherapy for salivary gland adenoid cystic carcinoma: survival assessment through a retrospective study exploiting real-world data extracted from data warehouseS Cavalieri, B Lombardi Stocchetti, N Crippa, et al.
Tumori|January 1, 1997
[Evaluation of quality of life in oncology. Rationale and objectives of the first phase of the Quality of Life in Oncology project]M Costantini, E Mencaglia, P Di Giulio, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 13, 2000
Cancer patients as 'experts' in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO)M Costantini, E Mencaglia, P D Giulio, et al.
ESMO Open|May 1, 2025
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)R Galot, C Le Tourneau, L Licitra, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy eraA Alberti, C Gurizzan, C Resteghini, et al.
ESMO Open|February 22, 2025
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upC Resteghini, B Baujat, P Bossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitorsK D Lewis, K Peris, A Sekulic, et al.
ESMO Open|November 29, 2021
Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neckB Keam, J-P Machiels, H R Kim, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
ESMO Open|January 17, 2026
A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancersS Alfieri, S Rota, R Romanò, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2020
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III studyR L Ferris, R Haddad, C Even, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Radiochemotherapy for salivary gland adenoid cystic carcinoma: survival assessment through a retrospective study exploiting real-world data extracted from data warehouseS Cavalieri, B Lombardi Stocchetti, N Crippa, et al.
Tumori|January 1, 1997
[Evaluation of quality of life in oncology. Rationale and objectives of the first phase of the Quality of Life in Oncology project]M Costantini, E Mencaglia, P Di Giulio, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 13, 2000
Cancer patients as 'experts' in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO)M Costantini, E Mencaglia, P D Giulio, et al.
ESMO Open|May 1, 2025
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)R Galot, C Le Tourneau, L Licitra, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy eraA Alberti, C Gurizzan, C Resteghini, et al.
ESMO Open|February 22, 2025
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upC Resteghini, B Baujat, P Bossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitorsK D Lewis, K Peris, A Sekulic, et al.
ESMO Open|November 29, 2021
Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neckB Keam, J-P Machiels, H R Kim, et al.
Pageof 11